Dudediligence.

MoonLake Immunotherapeutics

MLTXNASDAQ · Pharmaceutical Preparations
Write an idea

Filings

Newest first

The annual , the quarterly and the filed between them when something material happens.

  1. Sep 308-KOther events8.01
  2. Aug 1413GPassive stake of 5% or more (13G), filed by T. Rowe Price Investment Management
  3. Aug 1010-QQuarterly report
  4. Aug 108-KResults of operations and Regulation FD disclosure2.027.019.01
  5. Jul 148-KOther events8.01
  6. Jun 258-KMaterial agreement1.019.01
  7. Jun 24424B5Prospectus for an offering
  8. Jun 22424B5Prospectus for an offering
  9. Jun 228-KRegulation FD disclosure and other events7.018.019.01
  10. Jun 98-KOfficer or director change and shareholder vote5.025.079.01
  11. Jun 18-KMaterial agreement1.01
  12. May 1110-QQuarterly report
  13. May 118-KResults of operations and Regulation FD disclosure2.027.019.01
  14. Feb 2510-KAnnual report
  15. Feb 238-KMaterial agreement and results of operations1.012.022.035.027.018.019.01
  16. Jan 88-KOther events8.019.01
  17. Nov 5, 20258-KMaterial agreement1.019.01
  18. Nov 5, 2025424B5Prospectus for an offering
  19. Nov 5, 202510-QQuarterly report
  20. Nov 5, 20258-KResults of operations and Regulation FD disclosure2.027.019.01
  21. Sep 29, 20258-KOther events8.019.01
  22. Aug 5, 202510-QQuarterly report
  23. Aug 5, 20258-KResults of operations2.02
  24. Jun 6, 20258-KShareholder vote5.07
  25. May 12, 202510-QQuarterly report
  26. May 12, 20258-KResults of operations2.02
  27. Apr 29, 20258-KRegulation FD disclosure7.01
  28. Apr 3, 20258-KMaterial agreement and Regulation FD disclosure1.012.037.019.01
  29. Feb 26, 202510-KAnnual report
  30. Feb 26, 20258-KResults of operations2.02
  31. Dec 18, 20248-KOfficer or director change5.02
  32. Nov 7, 202410-QQuarterly report
  33. Nov 7, 20248-KResults of operations2.02